Request more info

EMEA: +44 (0) 1869 255758

US: +1 (800) 450 2403

Email: sales@thecompliancemap.com

News

Bevacizumab added to Proposition 65 List

13th Mar 2019

EMEA sales & customer support

+44 (0) 1869 255758

US sales & customer support

+1 (800) 450 2403

Email sales & customer support

sales@thecompliancemap.com
The Compliance Map Logo Watermark

Bevacizumab has been added to the list based on a formal requirement by the US Food and Drug Administration (FDA) that the chemical be identified or labeled as causing reproductive toxicity (developmental and female endpoints). 

Businesses are required to provide a clear and reasonable warning before knowingly and intentionally exposing anyone to Prop65 listed chemicals one year after being added to the list.

 

Get in touch to find out how we can help with your compliance requirements

EMEA: +44 (0) 1869 255758 /
US: +1 (800) 450 2403 /
Email: sales@thecompliancemap.com

Medical-equipment-AdobeStock_496913386-scaled.jpeg?w=1024&h=683&scale

New RoHS exemption added for in-vitro medical devices

24th Jul 2023

Read article
Cars-scrap-AdobeStock_55532335-scaled.jpeg?w=1024&h=683&scale

European Commission consults on End of Life Vehicles Regulation

17th Jul 2023

Read article
AdobeStock_502095230-scaled.jpeg?w=1024&h=603&scale

New CLP obligations introduced

5th Apr 2023

Read article